Moderna's Q4 profit and sales exceeded Wall Street's expecta...

Moderna's Q4 profit and sales exceeded Wall Street's expectations, boosting its stock. The company's promising efforts to diversify its drug portfolio, including an RSV vaccine and a new cancer treatment, are noted despite efficacy concerns.